TickerKhojOpen the scanner

Comparison · NSE · data 2026-11-03

Jay Shree Tea & Industries Ltd. vs Nath Bio-Genes (India) Ltd.

In plain words

Size: Nath Bio-Genes (India) Ltd. is about 1.1 times the market value of Jay Shree Tea & Industries Ltd..

Return on equity: Nath Bio-Genes (India) Ltd. 6.3% vs Jay Shree Tea & Industries Ltd. -6.1%.

Debt to equity: Jay Shree Tea & Industries Ltd. 1.06 vs Nath Bio-Genes (India) Ltd. 0.2.

Differences in the numbers, not a recommendation of either stock.

Side by side

JAYSREETEANATHBIOGEN
Price₹80.78₹131.88
Market cap₹224 cr₹250 cr
P/E—6.5
P/B——
ROE-6.1%6.3%
ROCE-14.4%7.3%
Debt / equity1.060.2
Operating margin0.2%9.3%
Dividend yield0.64%1.52%
Sales growth, 3 years (yearly)5.2%15.2%
Profit growth, 3 years (yearly)—5.9%
1-year return-16.3%-21.0%
Revenue, last 12 months₹946 cr₹490 cr
Net profit, last 12 months₹-22 cr₹39 cr
Latest quarterJun 2026Jun 2026
Quarter net profit₹-6 cr₹32 cr
Quarter profit vs a year earlier—-13.5%
Promoter holding55.06%45.60%
Health checkWeak (1.4/10)Average (5.8/10)

Common questions

Which earns a higher return on equity?

Nath Bio-Genes (India) Ltd. (6.3% against -6.1%).

Which carries more debt?

Jay Shree Tea & Industries Ltd. has the higher debt-to-equity ratio (1.06 against 0.2).

JAYSREETEA pageNATHBIOGEN page

Share on WhatsAppShare on Telegram